Cargando…
Targeted sequencing identifies the mutational signature of double primary and metastatic malignancies: a case report
BACKGROUND: The accurate identification of the tissue of origin is critical for optimal management of cancer patients particularly those who develop multiple malignancies; however, conventional diagnostic methods at times may fail to provide conclusive diagnosis of the origin of the malignancy. Here...
Autores principales: | Rao, Chuangzhou, Nie, Liangqin, Miao, Xiaobo, Lizaso, Analyn, Zhao, Guofang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727526/ https://www.ncbi.nlm.nih.gov/pubmed/31484545 http://dx.doi.org/10.1186/s13000-019-0874-5 |
Ejemplares similares
-
The clinical characteristics and prognostic analysis of Chinese advanced NSCLC patients based on circulating tumor DNA sequencing
por: Rao, Chuangzhou, et al.
Publicado: (2018) -
Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK C1156F mutation
por: Rao, Chuangzhou, et al.
Publicado: (2022) -
Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case report
por: Zhou, Yuling, et al.
Publicado: (2020) -
Tumor mutation burden derived from small next generation sequencing targeted gene panel as an initial screening method
por: Tang, Yuan, et al.
Publicado: (2020) -
Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients
por: Tao, Zhonghua, et al.
Publicado: (2020)